With the upcoming change of Prime Minister, the UK’s life sciences sector has called on Government to deliver policy continuity, unlock scale-up investment and improve patient access to new medicines. At a UK BioIndustry Association (BIA) industry roundtable with Dr Zubir Ahmed MP, the life sciences and biotech industry emphasised that the UK has the […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!